about
Efficient adenovirus-mediated gene transfer into primary T cells and thymocytes in a new coxsackie/adenovirus receptor transgenic modelMitigating age-related immune dysfunction heightens the efficacy of tumor immunotherapy in aged mice.eRapa restores a normal life span in a FAP mouse model.Sequential intravesical mitomycin plus Bacillus Calmette-Guérin for non-muscle-invasive urothelial bladder carcinoma: translational and phase I clinical trialGene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.Immunotherapy for ovarian cancer.Prevention of carcinogen and inflammation-induced dermal cancer by oral rapamycin includes reducing genetic damageB7-H1-dependent sex-related differences in tumor immunity and immunotherapy responses.Chronic mTOR inhibition in mice with rapamycin alters T, B, myeloid, and innate lymphoid cells and gut flora and prolongs life of immune-deficient mice.Activated Notch2 potentiates CD8 lineage maturation and promotes the selective development of B1 B cells.Vorinostat and hydroxychloroquine improve immunity and inhibit autophagy in metastatic colorectal cancer.Biphasic Rapamycin Effects in Lymphoma and Carcinoma Treatment.Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma.Considerations for successful cancer immunotherapy in aged hosts.Aging-associated B7-DC+ B cells enhance anti-tumor immunity via Th1 and Th17 induction.Immune-Stimulatory Effects of Rapamycin Are Mediated by Stimulation of Antitumor γδ T Cells.Age-related changes in specificity of human natural autoantibodies to thyroglobulinSelection of the expressed B cell repertoire by infusion of normal immunoglobulin G in a patient with autoimmune thyroiditis
P50
Q24792408-82538220-B5BC-4C08-9C3F-BCDD317BC64EQ30513468-A17A66C2-8A4B-46C7-9A5C-25C204C51E5CQ33760600-4D3E441D-DE79-4D12-96C3-325AD7F1B0CBQ34979760-E7E311DF-87B6-43F6-A269-27184A1AD301Q34981906-B8455308-2E52-436D-A828-C6086F6F0685Q35164189-C529C735-86F0-46B8-8995-E754F0EC2181Q35563024-5469D3B2-43FF-4016-B54B-ECF89DDF507DQ35630407-1512201E-0071-43B6-8003-5BF6406562E4Q35758129-7EBCA130-355F-4648-AC0F-853C1E2AF5AFQ37061440-5D886CBD-3A42-4177-8745-DDF35BA43C7EQ37644824-10D55A1D-39BF-41A6-BAFA-BBF84B63C3E8Q38741294-DC20075C-7B5A-4952-A820-C905894A68C7Q38743564-CD7FEBAE-A9E2-4824-A890-3C174E1F464CQ38815953-0822A959-C918-4494-A62B-2D287BF499DDQ39691338-2BF9FC8B-040F-4F24-A5E8-573304A0CAC4Q40604193-A234DBF8-0DD9-4DC6-A2EB-09FCC0277956Q72105737-FFA1F999-CEB0-4BB8-B9D6-3DBA7E2CF34AQ72564618-EE9490CD-9EC2-4FF6-9F1C-CB0ABB7CBD21
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Vincent Hurez
@ast
Vincent Hurez
@en
Vincent Hurez
@es
Vincent Hurez
@nl
Vincent Hurez
@sl
type
label
Vincent Hurez
@ast
Vincent Hurez
@en
Vincent Hurez
@es
Vincent Hurez
@nl
Vincent Hurez
@sl
prefLabel
Vincent Hurez
@ast
Vincent Hurez
@en
Vincent Hurez
@es
Vincent Hurez
@nl
Vincent Hurez
@sl
P106
P1153
57191388567
6701381332
P21
P31
P496
0000-0003-0271-4157